×
About 319,784 results

ALLMedicine™ Hypertension Center

Research & Reviews  146,035 results

The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting STA...
https://doi.org/10.1038/s41440-020-00568-z
Hypertension Research : Official Journal of the Japanese Society of Hypertension; Li Y, Yang X et. al.

Oct 30th, 2020 - Gestational hypertension is a high-risk disease for women, and the current treatments have limited efficacies. Here, we aimed to evaluate troxerutin, which is a natural monomer of flavone, in the treatment of gestational hypertension. Pregnant mic...

Heart Rate Variability in Patients with Hypertension: the Effect of Metabolic Syndrome ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582062
Cardiovascular Therapeutics; Maciorowska M, Krzesiński P et. al.

Oct 30th, 2020 - Metabolic syndrome (MetS) is a combination of factors which, collectively, increase cardiovascular risk to a greater extent than each of them separately. Previous studies showed high cardiovascular risk to be associated with autonomic nervous syst...

Chronic Kidney Disease.
https://doi.org/10.1016/j.pop.2020.08.001
Primary Care; Charles C, Ferris AH

Oct 30th, 2020 - Chronic kidney disease is encountered by the primary care physician, in no small part owing to the high rates of hypertension and diabetes, the 2 most common etiologies of chronic kidney disease in the United States. As a primary care physician, i...

Nephrotic Syndrome.
https://doi.org/10.1016/j.pop.2020.08.002
Primary Care; Politano SA, Colbert GB et. al.

Oct 30th, 2020 - Nephrotic syndrome is one cause of end-stage kidney disease. Because edema is a common presenting feature and hypertension and dyslipidemia are often present in nephrotic syndrome, it is important for the primary care physician to suspect this ent...

Nephritic Syndrome.
https://doi.org/10.1016/j.pop.2020.08.003
Primary Care; Lamba P, Nam KH et. al.

Oct 30th, 2020 - Nephritic syndrome is a constellation of hematuria, proteinuria, hypertension, and in some cases acute kidney injury and fluid retention characteristic of acute glomerulonephritis. Infection-related glomerulonephritis, IgA nephropathy, lupus nephr...

see more →

Guidelines  537 results

Diabetes and kidney cancer risk among post-menopausal women: The Iowa women’s health study
https://www.maturitas.org/article/S0378-5122(20)30341-8/fulltext
Maturitas Wang S

Aug 10th, 2020 - Many studies have reported a positive association between diabetes and kidney cancer. However, it is unclear whether diabetes is a risk factor for kidney cancer independent of other risk factors, such as obesity and hypertension. We comprehensivel...

Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmona...
https://doi.org/10.1016/j.cjca.2019.11.041
The Canadian Journal of Cardiology; Hirani N, Brunner NW et. al.

Jul 19th, 2020 - The landscape of pulmonary hypertension (PH) has changed significantly since the last Canadian Cardiovascular Society/Canadian Thoracic Society position statement in 2005. Since then, advances in our understanding of the pathophysiology of PH and ...

Recommendations for the management of patients with immune-mediated kidney disease duri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313759
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association; Anders HJ, Bruchfeld A et. al.

May 23rd, 2020 - The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity...

Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk...
https://doi.org/10.1016/j.cjca.2020.02.086
The Canadian Journal of Cardiology; Rabi DM, McBrien KA et. al.

May 10th, 2020 - Hypertension Canada's 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Cana...

Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Resista...
https://doi.org/10.1016/j.cjca.2020.02.083
The Canadian Journal of Cardiology; Hiremath S, Sapir-Pichhadze R et. al.

May 10th, 2020 - We present Hypertension Canada's inaugural evidence-based recommendations for the diagnosis and management of resistant hypertension. Hypertension is present in 21% of the Canadian population, and among those with hypertension, resistant hypertens...

see more →

Drugs  8,437 results see all →

Clinicaltrials.gov  157,990 results

Tadalafil - tadalafil tablet, film coated-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=efa03afa-c412-4b31-bf26-7c3a6f7311af

Oct 31st, 2020 - Tadalafil tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NY...

Amlodipine besylate - amlodipine besylate tablet-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=003dd1ec-16f8-4f96-b6a8-c4689d35892a

Oct 31st, 2020 - Amlodipine besylate tablets are calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: •Hypertension (1.1) о  Amlodipine besylate tablets are indicated for the treat...

Telmisartan and hydrochlorothiazide - telmisartan and hydrochlorothiazide tablet-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b88054b3-fafa-4b4e-acf5-5294e5555720

Oct 31st, 2020 - Telmisartan and hydrochlorothiazide tablets are combination of an angiotensin II receptor blocker (ARB) and a thiazide diuretic indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. Lowe...

The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting STA...
https://doi.org/10.1038/s41440-020-00568-z
Hypertension Research : Official Journal of the Japanese Society of Hypertension; Li Y, Yang X et. al.

Oct 30th, 2020 - Gestational hypertension is a high-risk disease for women, and the current treatments have limited efficacies. Here, we aimed to evaluate troxerutin, which is a natural monomer of flavone, in the treatment of gestational hypertension. Pregnant mic...

Heart Rate Variability in Patients with Hypertension: the Effect of Metabolic Syndrome ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582062
Cardiovascular Therapeutics; Maciorowska M, Krzesiński P et. al.

Oct 30th, 2020 - Metabolic syndrome (MetS) is a combination of factors which, collectively, increase cardiovascular risk to a greater extent than each of them separately. Previous studies showed high cardiovascular risk to be associated with autonomic nervous syst...

see more →

News  6,610 results

Switching to Riociguat Effective for Some Patients With PAH
https://www.medscape.com/viewarticle/939809

Oct 26th, 2020 - In patients with intermediate-risk pulmonary arterial hypertension (PAH) who are not at treatment goal on standard therapy, switching to riociguat is a promising strategy across a broad range of patient subgroups, an investigator said at the annua...

ECG Challenge: Abdominal Pain and Diarrhea in a Heart Disease Patient
https://www.medscape.com/viewarticle/938988

Oct 21st, 2020 - A 72-year-old man with a history of hypertension and coronary artery disease presents to the emergency department complaining of weakness, abdominal pain, and diarrhea. His physical examination is unremarkable. An ECG is obtained. Figure 1. Courte...

Selexipag Has No Effect on Daily Activity in PAH Patients
https://www.medscape.com/viewarticle/939444

Oct 19th, 2020 - Selexipag (Uptravi) does not change the level of daily activity of patients with pulmonary arterial hypertension (PAH), results from the phase 4 TRACE trial suggest. "We had no preconceived idea if this drug would improve exercise capacity," said ...

Selexipag Has No Effect on Daily Activity in PAH Patients
https://www.staging.medscape.com/viewarticle/939444

Oct 19th, 2020 - Selexipag (Uptravi) does not change the level of daily activity of patients with pulmonary arterial hypertension (PAH), results from the phase 4 TRACE trial suggest. "We had no preconceived idea if this drug would improve exercise capacity," said ...

Bariatric Surgery Tied to Lower Aortic Dissection Risk
https://www.medscape.com/viewarticle/939170

Oct 14th, 2020 - People who have undergone bariatric surgery appear less likely to suffer an aortic dissection than other adults with obesity, researchers say. The finding is the latest in a series of benefits researchers have linked to the surgery, not all of whi...

see more →

Patient Education  175 results see all →